BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brinkman K, Smeitink JA, Romijn JA, Reiss P. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. The Lancet 1999;354:1112-5. [DOI: 10.1016/s0140-6736(99)06102-4] [Cited by in Crossref: 614] [Cited by in F6Publishing: 121] [Article Influence: 26.7] [Reference Citation Analysis]
Number Citing Articles
1 Mann JP, Savage DB. What lipodystrophies teach us about the metabolic syndrome. J Clin Invest 2019;129:4009-21. [PMID: 31380809 DOI: 10.1172/JCI129190] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
2 Shafer RW, Smeaton LM, Robbins GK, De Gruttola V, Snyder SW, D'Aquila RT, Johnson VA, Morse GD, Nokta MA, Martinez AI, Gripshover BM, Kaul P, Haubrich R, Swingle M, McCarty SD, Vella S, Hirsch MS, Merigan TC; AIDS Clinical Trials Group 384 Team. Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med 2003;349:2304-15. [PMID: 14668456 DOI: 10.1056/NEJMoa030265] [Cited by in Crossref: 161] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
3 Ortiz M, Poloni ES, Furrer H, Kovari H, Martinez R, Arnedo M, Elzi L, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Ledergerber B, Günthard HF, Telenti A, Tarr PE; Swiss HIV Cohort Study. No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy. J Infect Dis 2011;203:620-4. [PMID: 21227914 DOI: 10.1093/infdis/jiq106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
4 Thomas A, Dobbels EFM, Springer PE, Ackermann C, Cotton MF, Laughton B. Favourable outcome in a child with symptomatic diagnosis of Glutaric aciduria type 1 despite vertical HIV infection and minor head trauma. Metab Brain Dis 2018;33:537-44. [PMID: 29427049 DOI: 10.1007/s11011-018-0196-4] [Reference Citation Analysis]
5 Handforth J, Sharland M. Triple nucleoside reverse transcriptase inhibitor therapy in children. Paediatr Drugs 2004;6:147-59. [PMID: 15170362 DOI: 10.2165/00148581-200406030-00002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
6 Van Dyke RB, Wang L, Williams PL; Pediatric AIDS Clinical Trials Group 219C Team. Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children. J Infect Dis 2008;198:1599-608. [PMID: 19000014 DOI: 10.1086/593022] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
7 Raboud JM, Diong C, Carr A, Grinspoon S, Mulligan K, Sutinen J, Rozenbaum W, Cavalcanti RB, Wand H, Costagliola D, Walmsley S; Glitazone and Lipoatrophy Meta-Analysis Working Group. A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy. HIV Clin Trials 2010;11:39-50. [PMID: 20400410 DOI: 10.1310/hct1101-39] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
8 Kim RJ, Rutstein RM. Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients. Paediatr Drugs 2010;12:187-99. [PMID: 20481647 DOI: 10.2165/11532520-000000000-00000] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
9 Akanbi MO, Scarsi KK, Taiwo B, Murphy RL. Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection. Expert Opin Pharmacother 2012;13:65-79. [PMID: 22149368 DOI: 10.1517/14656566.2012.642865] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
10 Selvaraj S, Ghebremichael M, Li M, Foli Y, Langs-Barlow A, Ogbuagu A, Barakat L, Tubridy E, Edifor R, Lam W, Cheng YC, Paintsil E. Antiretroviral therapy-induced mitochondrial toxicity: potential mechanisms beyond polymerase-γ inhibition. Clin Pharmacol Ther 2014;96:110-20. [PMID: 24637942 DOI: 10.1038/clpt.2014.64] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
11 Plosker GL, Noble S. Indinavir: a review of its use in the management of HIV infection. Drugs 1999;58:1165-203. [PMID: 10651394 DOI: 10.2165/00003495-199958060-00011] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
12 Tripathi A, Thangaraj A, Chivero ET, Periyasamy P, Burkovetskaya ME, Niu F, Guo ML, Buch S. N-Acetylcysteine Reverses Antiretroviral-Mediated Microglial Activation by Attenuating Autophagy-Lysosomal Dysfunction. Front Neurol 2020;11:840. [PMID: 33013619 DOI: 10.3389/fneur.2020.00840] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Ortiz GM, Wellons M, Brancato J, Vo HT, Zinn RL, Clarkson DE, Van Loon K, Bonhoeffer S, Miralles GD, Montefiori D, Bartlett JA, Nixon DF. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc Natl Acad Sci U S A 2001;98:13288-93. [PMID: 11687611 DOI: 10.1073/pnas.221452198] [Cited by in Crossref: 129] [Cited by in F6Publishing: 118] [Article Influence: 6.1] [Reference Citation Analysis]
14 Mallon PW, Cooper DA, Carr A. HIV-associated lipodystrophy. HIV Med 2001;2:166-73. [PMID: 11737397 DOI: 10.1046/j.1468-1293.2001.00071.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
15 Lopes de Campos WR, Coopusamy D, Morris L, Mayosi BM, Khati M. Cytotoxicological analysis of a gp120 binding aptamer with cross-clade human immunodeficiency virus type 1 entry inhibition properties: comparison to conventional antiretrovirals. Antimicrob Agents Chemother 2009;53:3056-64. [PMID: 19364860 DOI: 10.1128/AAC.01502-08] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
16 Hendrickson SL, Hutcheson HB, Ruiz-Pesini E, Poole JC, Lautenberger J, Sezgin E, Kingsley L, Goedert JJ, Vlahov D, Donfield S, Wallace DC, O'Brien SJ. Mitochondrial DNA haplogroups influence AIDS progression. AIDS 2008;22:2429-39. [PMID: 19005266 DOI: 10.1097/QAD.0b013e32831940bb] [Cited by in Crossref: 66] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
17 Janas MM, Zlatev I, Liu J, Jiang Y, Barros SA, Sutherland JE, Davis WP, Liu J, Brown CR, Liu X, Schlegel MK, Blair L, Zhang X, Das B, Tran C, Aluri K, Li J, Agarwal S, Indrakanti R, Charisse K, Nair J, Matsuda S, Rajeev KG, Zimmermann T, Sepp-Lorenzino L, Xu Y, Akinc A, Fitzgerald K, Vaishnaw AK, Smith PF, Manoharan M, Jadhav V, Wu JT, Maier MA. Safety evaluation of 2'-deoxy-2'-fluoro nucleotides in GalNAc-siRNA conjugates. Nucleic Acids Res 2019;47:3306-20. [PMID: 30820542 DOI: 10.1093/nar/gkz140] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
18 Phoa LL, Toelle BG, Ng K, Marks GB. Effects of gas and other fume emitting heaters on the development of asthma during childhood. Thorax 2004;59:741-5. [PMID: 15333848 DOI: 10.1136/thx.2003.014241] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
19 van Wijk JP, Cabezas MC. Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution. Int J Vasc Med 2012;2012:201027. [PMID: 21876813 DOI: 10.1155/2012/201027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
20 Stuyver LJ, Lostia S, Adams M, Mathew JS, Pai BS, Grier J, Tharnish PM, Choi Y, Chong Y, Choo H, Chu CK, Otto MJ, Schinazi RF. Antiviral activities and cellular toxicities of modified 2',3'-dideoxy-2',3'-didehydrocytidine analogues. Antimicrob Agents Chemother 2002;46:3854-60. [PMID: 12435688 DOI: 10.1128/AAC.46.12.3854-3860.2002] [Cited by in Crossref: 107] [Cited by in F6Publishing: 69] [Article Influence: 5.6] [Reference Citation Analysis]
21 Blanco Quintana F, García Benayas T, Soriano Vázquez V. [Lipodystrophy syndrome associated with the human immunodeficiency syndrome virus (I). General characteristics and etiopathogenesis]. Rev Clin Esp 2002;202:27-31. [PMID: 11940431 DOI: 10.1016/s0014-2565(02)70976-4] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
22 Chastain DB, Henderson H, Stover KR. Epidemiology and management of antiretroviral-associated cardiovascular disease. Open AIDS J 2015;9:23-37. [PMID: 25866592 DOI: 10.2174/1874613601509010023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
23 Tripathi A, Thangaraj A, Chivero ET, Periyasamy P, Callen S, Burkovetskaya ME, Guo ML, Buch S. Antiretroviral-Mediated Microglial Activation Involves Dysregulated Autophagy and Lysosomal Dysfunction. Cells 2019;8:E1168. [PMID: 31569373 DOI: 10.3390/cells8101168] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
24 Akita S, Suzuki K, Yoshimoto H, Ohtsuru A, Hirano A, Yamashita S. Cellular Mechanism Underlying Highly-Active or Antiretroviral Therapy-Induced Lipodystrophy: Atazanavir, a Protease Inhibitor, Compromises Adipogenic Conversion of Adipose-Derived Stem/Progenitor Cells through Accelerating ER Stress-Mediated Cell Death in Differentiating Adipocytes. Int J Mol Sci 2021;22:2114. [PMID: 33672735 DOI: 10.3390/ijms22042114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yuh B, Tate J, Butt AA, Crothers K, Freiberg M, Leaf D, Logeais M, Rimland D, Rodriguez-Barradas MC, Ruser C, Justice AC. Weight change after antiretroviral therapy and mortality. Clin Infect Dis 2015;60:1852-9. [PMID: 25761868 DOI: 10.1093/cid/civ192] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 10.3] [Reference Citation Analysis]
26 Stankov MV, Schmidt RE, Behrens GM, German Competence Network HIV/AIDS. Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion. Antimicrob Agents Chemother. 2008;52:2882-2889. [PMID: 18474584 DOI: 10.1128/aac.01505-07] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
27 Lewis W, Kohler JJ, Hosseini SH, Haase CP, Copeland WC, Bienstock RJ, Ludaway T, McNaught J, Russ R, Stuart T, Santoianni R. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis. AIDS 2006;20:675-84. [PMID: 16514297 DOI: 10.1097/01.aids.0000216367.23325.58] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 4.7] [Reference Citation Analysis]
28 Dalakas MC. Peripheral neuropathy and antiretroviral drugs. J Peripher Nerv Syst 2001;6:14-20. [PMID: 11293802 DOI: 10.1046/j.1529-8027.2001.006001014.x] [Cited by in Crossref: 147] [Cited by in F6Publishing: 130] [Article Influence: 7.0] [Reference Citation Analysis]
29 Lyall E, Blott M, De Ruiter A, Hawkins D, Mercy D, Mitchla Z, Newell M, O'shea S, Smith J, Sunderland J, Webb R, Taylor G. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission: British HIV Association. HIV Medicine 2001;2:314-34. [DOI: 10.1046/j.1464-2662.2001.00082.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
30 Manfredi R. HIV disease and advanced age: an increasing therapeutic challenge. Drugs Aging 2002;19:647-69. [PMID: 12381235 DOI: 10.2165/00002512-200219090-00003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 2.3] [Reference Citation Analysis]
31 Bellini E, Grieco MP, Raposio E. The science behind autologous fat grafting. Ann Med Surg (Lond) 2017;24:65-73. [PMID: 29188051 DOI: 10.1016/j.amsu.2017.11.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 12.0] [Reference Citation Analysis]
32 Glenda Winson S. Management of HIV-Associated Diarrhea and Wasting. Journal of the Association of Nurses in AIDS Care 2001;12:55-62. [DOI: 10.1016/s1055-3290(06)60158-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
33 Stoker ML, Newport E, Hulit JC, West AP, Morten KJ. Impact of pharmacological agents on mitochondrial function: a growing opportunity? Biochem Soc Trans 2019;47:1757-72. [PMID: 31696924 DOI: 10.1042/BST20190280] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
34 Koethe JR. Adipose Tissue in HIV Infection. Compr Physiol 2017;7:1339-57. [PMID: 28915327 DOI: 10.1002/cphy.c160028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
35 Weldegebreal F, Mitiku H, Teklemariam Z. Magnitude of adverse drug reaction and associated factors among HIV-infected adults on antiretroviral therapy in Hiwot Fana specialized university hospital, eastern Ethiopia. Pan Afr Med J 2016;24:255. [PMID: 27800108 DOI: 10.11604/pamj.2016.24.255.8356] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
36 Cheng DM, Libman H, Bridden C, Saitz R, Samet JH. Alcohol consumption and lipodystrophy in HIV-infected adults with alcohol problems. Alcohol 2009;43:65-71. [PMID: 19185212 DOI: 10.1016/j.alcohol.2008.09.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
37 Sohl CD, Kasiviswanathan R, Kim J, Pradere U, Schinazi RF, Copeland WC, Mitsuya H, Baba M, Anderson KS. Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptase. Mol Pharmacol 2012;82:125-33. [PMID: 22513406 DOI: 10.1124/mol.112.078758] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
38 Gebo KA. Epidemiology of HIV and response to antiretroviral therapy in the middle aged and elderly. Aging health 2008;4:615-27. [PMID: 19915688 DOI: 10.2217/1745509X.4.6.615] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
39 de Boer R, Smith RL, De Vos WH, Manders EM, Brul S, van der Spek H. Caenorhabditis elegans as a Model System for Studying Drug Induced Mitochondrial Toxicity. PLoS One 2015;10:e0126220. [PMID: 25970180 DOI: 10.1371/journal.pone.0126220] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
40 Behrens GM, Stoll M, Schmidt RE. Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed? Drug Saf. 2000;23:57-76. [PMID: 10915032 DOI: 10.2165/00002018-200023010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Behrens GM, Boerner AR, Weber K, van den Hoff J, Ockenga J, Brabant G, Schmidt RE. Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy. J Clin Invest 2002;110:1319-27. [PMID: 12417571 DOI: 10.1172/JCI15626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 0.1] [Reference Citation Analysis]
42 Braithwaite RS, Conigliaro J, Roberts MS, Shechter S, Schaefer A, McGinnis K, Rodriguez MC, Rabeneck L, Bryant K, Justice AC. Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care. 2007;19:459-466. [PMID: 17453583 DOI: 10.1080/09540120601095734] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 6.3] [Reference Citation Analysis]
43 Phillips EJ, Knowles SR, Shear N. Cutaneous manifestations of antiviral therapy. Journal of the American Academy of Dermatology 2003;48:985-6. [DOI: 10.1067/mjd.2003.427] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
44 White AJ. Mitochondrial toxicity and HIV therapy. Sex Transm Infect. 2001;77:158-173. [PMID: 11402222 DOI: 10.1136/sti.77.3.158] [Cited by in Crossref: 133] [Cited by in F6Publishing: 121] [Article Influence: 6.3] [Reference Citation Analysis]
45 Deveaud C, Beauvoit B, Salin B, Schaeffer J, Rigoulet M. Regional differences in oxidative capacity of rat white adipose tissue are linked to the mitochondrial content of mature adipocytes. Mol Cell Biochem 2004;267:157-66. [PMID: 15663197 DOI: 10.1023/b:mcbi.0000049374.52989.9b] [Cited by in Crossref: 55] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
46 Stankov MV, Lücke T, Das AM, Schmidt RE, Behrens GM. Mitochondrial DNA depletion and respiratory chain activity in primary human subcutaneous adipocytes treated with nucleoside analogue reverse transcriptase inhibitors. Antimicrob Agents Chemother 2010;54:280-7. [PMID: 19805555 DOI: 10.1128/AAC.00914-09] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
47 Jao J, Abrams EJ. Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants. Pediatr Infect Dis J 2014;33:734-40. [PMID: 24378947 DOI: 10.1097/INF.0000000000000224] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
48 McComsey GA, Lo Re V 3rd, O'Riordan M, Walker UA, Lebrecht D, Baron E, Mounzer K, Frank I. Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study. Clin Infect Dis 2008;46:1290-6. [PMID: 18444869 DOI: 10.1086/529384] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
49 van der Heijden WA, van de Wijer L, Jaeger M, Grintjes K, Netea MG, Urbanus RT, van Crevel R, van den Heuvel LP, Brink M, Rodenburg RJ, de Groot PG, van der Ven AJ, de Mast Q. Long-term treated HIV infection is associated with platelet mitochondrial dysfunction. Sci Rep 2021;11:6246. [PMID: 33739024 DOI: 10.1038/s41598-021-85775-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Vujanović M, Brkić-Jovanović N, Ilić D, Drvendžija Z, Srdić-Galić B, Turkulov V, Brkić S, Marić D. Associations of visceral fat thickness and anthropometric measurements with non-alcoholic fatty liver disease development in male patients mono-infected with human immunodeficiency virus. South Afr J HIV Med 2019;20:968. [PMID: 31534788 DOI: 10.4102/sajhivmed.v20i1.968] [Reference Citation Analysis]
51 Maassen JA, Romijn JA, Heine RJ. Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. Diabetologia 2007;50:2036-41. [PMID: 17712547 DOI: 10.1007/s00125-007-0776-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
52 Deveaud C, Beauvoit B, Reynaud A, Bonnet J. Site-specific reduction of oxidative and lipid metabolism in adipose tissue of 3'-azido-3'-deoxythymidine-treated rats. Antimicrob Agents Chemother 2007;51:583-90. [PMID: 17158934 DOI: 10.1128/AAC.01078-06] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
53 Castillo SA, Hernandez JE, Brothers CH. Long-term safety and tolerability of the lamivudine/abacavir combination as components of highly active antiretroviral therapy. Drug Saf 2006;29:811-26. [PMID: 16944966 DOI: 10.2165/00002018-200629090-00005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
54 Note R, Maisonneuve C, Lettéron P, Peytavin G, Djouadi F, Igoudjil A, Guimont MC, Biour M, Pessayre D, Fromenty B. Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments. Antimicrob Agents Chemother 2003;47:3384-92. [PMID: 14576092 DOI: 10.1128/AAC.47.11.3384-3392.2003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
55 Leung VL, Glesby MJ. Pathogenesis and treatment of HIV lipohypertrophy. Curr Opin Infect Dis 2011;24:43-9. [PMID: 21124215 DOI: 10.1097/QCO.0b013e3283420eef] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
56 Singh RK, Yadav D, Rai D, Kumari G, Pannecouque C, De Clercq E. Synthesis, structure-activity relationship and antiviral activity of 3'-N,N-dimethylamino-2',3'-dideoxythymidine and its prodrugs. Eur J Med Chem 2010;45:3787-93. [PMID: 20538384 DOI: 10.1016/j.ejmech.2010.05.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
57 Setzer B, Lebrecht D, Walker UA. Pyrimidine nucleoside depletion sensitizes to the mitochondrial hepatotoxicity of the reverse transcriptase inhibitor stavudine. Am J Pathol 2008;172:681-90. [PMID: 18276780 DOI: 10.2353/ajpath.2008.070613] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
58 le Roux CW, Beckles MA, Besser GM, Pinching AJ, Davison AG. Cushing's syndrome secondary to inhaled corticosteroids mimicking HIV-associated lipodystrophy. HIV Med 2001;2:133-5. [PMID: 11737390 DOI: 10.1046/j.1468-1293.2001.00058.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
59 Walker UA, Brinkman K. NRTI induced mitochondrial toxicity as a mechanism for HAART related lipodystrophy: fact or fiction? HIV Med 2001;2:163-5. [PMID: 11737396 DOI: 10.1046/j.1464-2662.2001.00073.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
60 Hendrickson SL, Kingsley LA, Ruiz-Pesini E, Poole JC, Jacobson LP, Palella FJ, Bream JH, Wallace DC, O'Brien SJ. Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2009;51:111-6. [PMID: 19339895 DOI: 10.1097/QAI.0b013e3181a324d6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
61 Domingo P, Cabeza Mdel C, Torres F, Salazar J, Gutierrez Mdel M, Mateo MG, Martínez E, Domingo JC, Fernandez I, Villarroya F. Association of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapy. PLoS One. 2013;8:e57347. [PMID: 23468971 DOI: 10.1371/journal.pone.0057347] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
62 Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, Horne FM, Huebner RE, Janoff EN, Justice AC, Kuritzkes D, Nayfield SG, Plaeger SF, Schmader KE, Ashworth JR, Campanelli C, Clayton CP, Rada B, Woolard NF, High KP. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 2008;47:542-53. [PMID: 18627268 DOI: 10.1086/590150] [Cited by in Crossref: 369] [Cited by in F6Publishing: 355] [Article Influence: 26.4] [Reference Citation Analysis]
63 Mamiafo CT, Moor VJ, Nansseu JR, Pieme CA, Tayou C, Yonkeu JN. Hyperlactatemia in a group of HIV patients living in Yaounde-Cameroon. AIDS Res Ther 2014;11:2. [PMID: 24428886 DOI: 10.1186/1742-6405-11-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
64 Lo Re V Rd, Zeldow B, Kallan MJ, Tate JP, Carbonari DM, Hennessy S, Kostman JR, Lim JK, Goetz MB, Gross R, Justice AC, Roy JA. Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection. Pharmacoepidemiol Drug Saf 2017;26:1172-81. [PMID: 28722244 DOI: 10.1002/pds.4258] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
65 Sutinen J. The effects of Thiazolidinediones on metabolic complications and Lipodystrophy in HIV-infected patients. PPAR Res 2009;2009:373524. [PMID: 19096512 DOI: 10.1155/2009/373524] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
66 Maassen JA, Romijn JA, Heine RJ. Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: do adipocytes consume sufficient amounts of oxygen to oxidise fatty acids? Diabetologia 2008;51:907-8. [PMID: 18317722 DOI: 10.1007/s00125-008-0963-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
67 van Welzen BJ, Mudrikova T, El Idrissi A, Hoepelman AIM, Arends JE. A review of Non-Alcoholic Fatty Liver Disease in HIV-infected patients: The next big thing? Infect Dis Ther. 2019;8:33-50. [PMID: 30607807 DOI: 10.1007/s40121-018-0229-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
68 Hsu DC, Sereti I. Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection. Drugs 2016;76:533-49. [PMID: 26915027 DOI: 10.1007/s40265-016-0546-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
69 Robbins GK, De Gruttola V, Shafer RW, Smeaton LM, Snyder SW, Pettinelli C, Dubé MP, Fischl MA, Pollard RB, Delapenha R, Gedeon L, van der Horst C, Murphy RL, Becker MI, D'Aquila RT, Vella S, Merigan TC, Hirsch MS; AIDS Clinical Trials Group 384 Team. Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med 2003;349:2293-303. [PMID: 14668455 DOI: 10.1056/NEJMoa030264] [Cited by in Crossref: 249] [Cited by in F6Publishing: 80] [Article Influence: 13.1] [Reference Citation Analysis]
70 Anuurad E, Semrad A, Berglund L. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease. Metab Syndr Relat Disord 2009;7:401-10. [PMID: 19355810 DOI: 10.1089/met.2008.0096] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
71 Simonacci F, Bertozzi N, Grieco MP, Grignaffini E, Raposio E. Procedure, applications, and outcomes of autologous fat grafting. Ann Med Surg (Lond) 2017;20:49-60. [PMID: 28702187 DOI: 10.1016/j.amsu.2017.06.059] [Cited by in Crossref: 115] [Cited by in F6Publishing: 87] [Article Influence: 23.0] [Reference Citation Analysis]
72 Palacios R, Santos J, Camino X, Arazo P, Torres Perea R, Echevarrfa S, Ribera E, Sánchez de la Rosa R, Moreno Guillen S; Recover Study Group. Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study. Curr Ther Res Clin Exp 2005;66:117-29. [PMID: 24672118 DOI: 10.1016/j.curtheres.2005.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
73 McKay RM, McKay JP, Avery L, Graff JM. C elegans: a model for exploring the genetics of fat storage. Dev Cell 2003;4:131-42. [PMID: 12530969 DOI: 10.1016/s1534-5807(02)00411-2] [Cited by in Crossref: 210] [Cited by in F6Publishing: 133] [Article Influence: 11.1] [Reference Citation Analysis]
74 Nookala AR, Mitra J, Chaudhari NS, Hegde ML, Kumar A. An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge? J Alzheimers Dis 2017;60:S169-93. [PMID: 28800335 DOI: 10.3233/JAD-170473] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
75 Nachega JB, Trotta MP, Nelson M, Ammassari A. Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications. Curr HIV/AIDS Rep 2009;6:121-9. [PMID: 19589297 DOI: 10.1007/s11904-009-0017-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
76 Bonnet E, Ruidavets JB, Genoux A, Mabile L, Busato F, Obadia M, Prévoteau F, Marchou B, Massip P, Marion-Latard F, Delpierre C, Bernard J, Perret B. Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study. BMC Infect Dis 2013;13:293. [PMID: 23809140 DOI: 10.1186/1471-2334-13-293] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
77 Weimer LH. Medication-induced peripheral neuropathy. Curr Neurol Neurosci Rep 2003;3:86-92. [PMID: 12507417 DOI: 10.1007/s11910-003-0043-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
78 Hulgan T. Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update. Curr HIV/AIDS Rep 2018;15:223-32. [PMID: 29700760 DOI: 10.1007/s11904-018-0399-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
79 Flint OP, Noor MA, Hruz PW, Hylemon PB, Yarasheski K, Kotler DP, Parker RA, Bellamine A. The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications. Toxicol Pathol 2009;37:65-77. [PMID: 19171928 DOI: 10.1177/0192623308327119] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
80 Kallianpur KJ, Walker M, Gerschenson M, Shikuma CM, Gangcuangco LMA, Kohorn L, Libutti DE, Nir TM, Jahanshad N, Thompson PM, Paul R. Systemic Mitochondrial Oxidative Phosphorylation Protein Levels Correlate with Neuroimaging Measures in Chronically HIV-Infected Individuals. AIDS Res Hum Retroviruses 2020;36:83-91. [PMID: 31617381 DOI: 10.1089/AID.2019.0240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
81 Sterling RK, Contos MJ, Smith PG, Stravitz RT, Luketic VA, Fuchs M, Shiffman ML, Sanyal AJ. Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology 2008;47:1118-27. [PMID: 18366118 DOI: 10.1002/hep.22134] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
82 Joshi P, Prasad VR. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment). J Virol 2002;76:6545-57. [PMID: 12050367 DOI: 10.1128/jvi.76.13.6545-6557.2002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
83 McLinden R, Paris R, Polonis V, Close N, Su Z, Shikuma C, Margolis D, Kim J. Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170). AIDS 2012;26:1452. [PMID: 22767347 DOI: 10.1097/QAD.0b013e3283550b8e] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
84 Caron M, Vigouroux C, Bastard JP, Capeau J. Antiretroviral-related adipocyte dysfunction and lipodystrophy in HIV-infected patients: Alteration of the PPARγ-dependent pathways. PPAR Res 2009;2009:507141. [PMID: 19125203 DOI: 10.1155/2009/507141] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
85 Janoff EN, Smith PD. Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management. Gastroenterology. 2001;120:607-621. [PMID: 11179239 DOI: 10.1053/gast.2001.22427] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
86 Wang L, Sun R, Eriksson S. The kinetic effects on thymidine kinase 2 by enzyme-bound dTTP may explain the mitochondrial side effects of antiviral thymidine analogs. Antimicrob Agents Chemother 2011;55:2552-8. [PMID: 21444706 DOI: 10.1128/AAC.00109-11] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
87 Sohl CD, Singh K, Kasiviswanathan R, Copeland WC, Mitsuya H, Sarafianos SG, Anderson KS. Mechanism of interaction of human mitochondrial DNA polymerase γ with the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine indicates a low potential for host toxicity. Antimicrob Agents Chemother 2012;56:1630-4. [PMID: 22155823 DOI: 10.1128/AAC.05729-11] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
88 Lin H, Stankov MV, Hegermann J, Budida R, Panayotova-Dimitrova D, Schmidt RE, Behrens GMN. Zidovudine-Mediated Autophagy Inhibition Enhances Mitochondrial Toxicity in Muscle Cells. Antimicrob Agents Chemother 2019;63:e01443-18. [PMID: 30373793 DOI: 10.1128/AAC.01443-18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
89 Crakes KR, Santos Rocha C, Grishina I, Hirao LA, Napoli E, Gaulke CA, Fenton A, Datta S, Arredondo J, Marco ML, Sankaran-Walters S, Cortopassi G, Giulivi C, Dandekar S. PPARα-targeted mitochondrial bioenergetics mediate repair of intestinal barriers at the host-microbe intersection during SIV infection. Proc Natl Acad Sci U S A 2019;116:24819-29. [PMID: 31740620 DOI: 10.1073/pnas.1908977116] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
90 Srirattana K, St John JC. Manipulating the Mitochondrial Genome To Enhance Cattle Embryo Development. G3 (Bethesda) 2017;7:2065-80. [PMID: 28500053 DOI: 10.1534/g3.117.042655] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
91 Green ML. Evaluation and management of dyslipidemia in patients with HIV infection. J Gen Intern Med 2002;17:797-810. [PMID: 12390557 DOI: 10.1046/j.1525-1497.2002.20201.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
92 Smith KJ, Skelton HG. Peroxisomal proliferator-activated ligand therapy for HIV lipodystrophy: Ligand therapy for HIV lipodystrophy. Clinical and Experimental Dermatology 2001;26:155-61. [DOI: 10.1046/j.1365-2230.2001.00784.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
93 Hashim H, Sahari NS, Sazlly Lim SM, Hoo FK. Fatal Tenofovir-Associateacd Lactic Acidosis: A Case Report. Iran Red Crescent Med J 2015;17:e19546. [PMID: 26568856 DOI: 10.5812/ircmj.19546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
94 Williams D, Geraci A, Simpson DM. AIDS and AIDS-treatment neuropathies. Curr Neurol Neurosci Rep 2001;1:533-8. [PMID: 11898566 DOI: 10.1007/s11910-001-0058-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
95 Wagner TA, Lin CH, Tobin NH, Côté HC, Sloan DD, Jerome KR, Frenkel LM. Quantification of mitochondrial toxicity in HIV-infected individuals by quantitative PCR compared to flow cytometry. Cytometry B Clin Cytom 2013;84:55-8. [PMID: 23044657 DOI: 10.1002/cyto.b.21045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
96 Mausumee G, Frank S, Shawn C, Dara H, Zhao Y, Soleil PM, Sanderson TP, Michael G, Marc D. Nonclinical Safety Profile of BMS-986001, a Nucleoside Transcriptase Inhibitor for Combination Retroviral Therapy. Int J Toxicol 2014;33:204-18. [PMID: 24846376 DOI: 10.1177/1091581814529309] [Reference Citation Analysis]
97 Authier FJ, Gheradi RK. Peripheral neuropathies in HIV-infected patients in the era of HAART. Brain Pathol 2003;13:223-8. [PMID: 12744475 DOI: 10.1111/j.1750-3639.2003.tb00021.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
98 Deonarain J, Ramdial PK, Singh B. Bilateral lipomastia in men: a side effect of highly active antiretroviral therapy. Int J Surg Pathol 2008;16:171-5. [PMID: 18417674 DOI: 10.1177/1066896907307037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
99 Wohl DA. Considering metabolic issues when initiating HIV therapy. Curr HIV/AIDS Rep 2007;4:119-25. [PMID: 17883997 DOI: 10.1007/s11904-007-0018-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
100 Barlow-Mosha L, Eckard AR, McComsey GA, Musoke PM. Metabolic complications and treatment of perinatally HIV-infected children and adolescents. J Int AIDS Soc. 2013;16:18600. [PMID: 23782481 DOI: 10.7448/ias.16.1.18600] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
101 Hasse B, Iff M, Ledergerber B, Calmy A, Schmid P, Hauser C, Cavassini M, Bernasconi E, Marzolini C, Tarr PE, Aubert V, Barth J, Battegay M, Bernasconi E, Böni J, Bucher HC, Burton-Jeangros C, Calmy A, Cavassini M, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux CA, Gorgievski M, Günthard H, Haerry D, Hasse B, Hirsch HH, Hösli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos R, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Metzner K, Müller N, Nadal D, Pantaleo G, Rauch A, Regenass S, Rickenbach M, Rudin C, Schöni-Affolter F, Schmid P, Schultze D, Schüpbach J, Speck R, Staehelin C, Tarr P, Telenti A, Trkola A, Vernazza P, Weber R, Yerly S; Swiss HIV Cohort Study. Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study. Open Forum Infect Dis 2014;1:ofu040. [PMID: 25734114 DOI: 10.1093/ofid/ofu040] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
102 Suzuki K, Akita S, Yoshimoto H, Ohtsuru A, Hirano A, Yamashita S. Biological Features Implies Potential Use of Autologous Adipose-Derived Stem/Progenitor Cells in Wound Repair and Regenerations for the Patients with Lipodystrophy. Int J Mol Sci 2019;20:E5505. [PMID: 31694186 DOI: 10.3390/ijms20215505] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
103 Tebas P, Zhang J, Yarasheski K, Evans S, Fischl MA, Shevitz A, Feinberg J, Collier AC, Shikuma C, Brizz B, Sattler F; AIDS Clinical Trials Group (ACTG). Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s). J Acquir Immune Defic Syndr 2007;45:193-200. [PMID: 17527093 DOI: 10.1097/QAI.0b013e318042e204] [Cited by in Crossref: 40] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
104 Holzinger ER, Hulgan T, Ellis RJ, Samuels DC, Ritchie MD, Haas DW, Kallianpur AR, Bloss CS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Franklin DR, Rosario D, Selph D, Letendre S, Grant I; CHARTER Group. Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER. J Neurovirol 2012;18:511-20. [PMID: 23073667 DOI: 10.1007/s13365-012-0133-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
105 Claessens YE, Chiche JD, Mira JP, Cariou A. Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors. Crit Care 2003;7:226-32. [PMID: 12793872 DOI: 10.1186/cc2162] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
106 Koethe JR, McDonnell W, Kennedy A, Abana CO, Pilkinton M, Setliff I, Georgiev I, Barnett L, Hager CC, Smith R, Kalams SA, Hasty A, Mallal S. Adipose Tissue is Enriched for Activated and Late-Differentiated CD8+ T Cells and Shows Distinct CD8+ Receptor Usage, Compared With Blood in HIV-Infected Persons. J Acquir Immune Defic Syndr 2018;77:e14-21. [PMID: 29040163 DOI: 10.1097/QAI.0000000000001573] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
107 Behrens GM, Stoll M, Schmidt RE. Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed? Drug Saf 2000;23:57-76. [PMID: 10915032 DOI: 10.2165/00002018-200023010-00004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 3.2] [Reference Citation Analysis]
108 Ross AC, Hileman CO, Brown TT, Fedarko N, Storer N, Labbato D, McComsey GA. Bone effects of rosiglitazone in HIV-infected patients with lipoatrophy. HIV Clin Trials 2012;13:212-21. [PMID: 22849962 DOI: 10.1310/hct1304-212] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
109 Sun R, Eriksson S, Wang L. Zidovudine induces downregulation of mitochondrial deoxynucleoside kinases: implications for mitochondrial toxicity of antiviral nucleoside analogs. Antimicrob Agents Chemother 2014;58:6758-66. [PMID: 25182642 DOI: 10.1128/AAC.03613-14] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
110 Lindegaard B, Keller P, Bruunsgaard H, Gerstoft J, Pedersen BK. Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients. Clin Exp Immunol 2004;135:273-9. [PMID: 14738456 DOI: 10.1111/j.1365-2249.2004.02367.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
111 Wang F, Flint OP. BMS-986001, an HIV nucleoside reverse transcriptase inhibitor, does not degrade mitochondrial DNA in long-term primary cultures of cells isolated from human kidney, muscle, and adipose tissue. Antimicrob Agents Chemother 2013;57:6205-12. [PMID: 24080659 DOI: 10.1128/AAC.01206-13] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
112 Barroso S, Morén C, González-Segura À, Riba N, Arnaiz JA, Manriquez M, Santana G, Blanco JL, Larousse M, Loncà M, Lazzari E, Llopis J, Mallolas J, Miró O, Carné X, Gatell JM, Garrabou G, Martínez E. Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers. PLoS One 2019;14:e0216712. [PMID: 31120908 DOI: 10.1371/journal.pone.0216712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
113 Pan J, Mott M, Xi B, Hepner E, Guan M, Fousek K, Magnusson R, Tinsley R, Valdes F, Frankel P, Synold T, Chow WA. Phase I study of nelfinavir in liposarcoma. Cancer Chemother Pharmacol 2012;70:791-9. [PMID: 22983015 DOI: 10.1007/s00280-012-1961-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
114 Redhage LA, Shintani A, Haas DW, Emeagwali N, Markovic M, Oboho I, Mwenya C, Erdem H, Acosta EP, Morrow JD, Hulgan T. Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults. HIV Clin Trials 2009;10:181-92. [PMID: 19632957 DOI: 10.1310/hct1003-181] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
115 Bertrand L, Toborek M. Dysregulation of Endoplasmic Reticulum Stress and Autophagic Responses by the Antiretroviral Drug Efavirenz. Mol Pharmacol. 2015;88:304-315. [PMID: 25987489 DOI: 10.1124/mol.115.098590] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
116 El-Sabbagh AH. Modern trends in lipomodeling. GMS Interdiscip Plast Reconstr Surg DGPW 2017;6:Doc06. [PMID: 28401032 DOI: 10.3205/iprs000108] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
117 Markowitz M, Sarafianos SG. 4'-Ethynyl-2-fluoro-2'-deoxyadenosine, MK-8591: a novel HIV-1 reverse transcriptase translocation inhibitor. Curr Opin HIV AIDS 2018;13:294-9. [PMID: 29697468 DOI: 10.1097/COH.0000000000000467] [Cited by in Crossref: 44] [Cited by in F6Publishing: 17] [Article Influence: 14.7] [Reference Citation Analysis]
118 Koczor CA, Jiao Z, Fields E, Russ R, Ludaway T, Lewis W. AZT-induced mitochondrial toxicity: an epigenetic paradigm for dysregulation of gene expression through mitochondrial oxidative stress. Physiol Genomics 2015;47:447-54. [PMID: 26199398 DOI: 10.1152/physiolgenomics.00045.2015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
119 Morse CG, Voss JG, Rakocevic G, McLaughlin M, Vinton CL, Huber C, Hu X, Yang J, Huang da W, Logun C, Danner RL, Rangel ZG, Munson PJ, Orenstein JM, Rushing EJ, Lempicki RA, Dalakas MC, Kovacs JA. HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue. J Infect Dis 2012;205:1778-87. [PMID: 22476717 DOI: 10.1093/infdis/jis101] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
120 Glesby MJ, Albu J, Chiu YL, Ham K, Engelson E, He Q, Muthukrishnan V, Ginsberg HN, Donovan D, Ernst J, Lesser M, Kotler DP. Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial. PLoS One 2013;8:e61160. [PMID: 23593417 DOI: 10.1371/journal.pone.0061160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
121 Wohl DA. Body shape, lipid, and cardiovascular complications of HIV therapy. Curr HIV/AIDS Rep 2005;2:74-82. [PMID: 16091252 DOI: 10.1007/s11904-005-0022-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
122 Rodriguez M, Lapierre J, Ojha CR, Pawitwar S, Karuppan MKM, Kashanchi F, El-Hage N. Morphine counteracts the antiviral effect of antiretroviral drugs and causes upregulation of p62/SQSTM1 and histone-modifying enzymes in HIV-infected astrocytes. J Neurovirol 2019;25:263-74. [PMID: 30746609 DOI: 10.1007/s13365-018-0715-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
123 Schifitto G, Deng L, Yeh TM, Evans SR, Ernst T, Zhong J, Clifford D. Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals. J Neurovirol 2011;17:17-25. [PMID: 21181521 DOI: 10.1007/s13365-010-0010-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
124 Ngo JK, Pomatto LC, Davies KJ. Upregulation of the mitochondrial Lon Protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging. Redox Biol. 2013;1:258-264. [PMID: 24024159 DOI: 10.1016/j.redox.2013.01.015] [Cited by in Crossref: 99] [Cited by in F6Publishing: 96] [Article Influence: 11.0] [Reference Citation Analysis]
125 Bañó M, Morén C, Barroso S, Juárez DL, Guitart-Mampel M, González-Casacuberta I, Canto-Santos J, Lozano E, León A, Pedrol E, Miró Ò, Tobías E, Mallolas J, Rojas JF, Cardellach F, Martínez E, Garrabou G. Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients. Front Genet 2020;11:497. [PMID: 32528527 DOI: 10.3389/fgene.2020.00497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Grether-Beck S, Krutmann J. [Adipose tissue. Cellular and molecular principles]. Hautarzt 2010;61:838-46. [PMID: 20871971 DOI: 10.1007/s00105-010-1983-y] [Reference Citation Analysis]